Since 2016, Life Sciences companies that are members of the Association of the British Pharmaceutical industry (ABPI) have been required to disclose payments to British Healthcare Professionals (HCPs) and Healthcare Organizations (HCOs).
This payment information is available to the public in a central database that can be found on the ABPI website. 2016 transfers of value have now been published, and Polaris has analyzed the information disclosed.
Analysis of 2016 payments
In 2016, payments to British HCPs and HCOs increased by 25% reaching £454.4 million, while the number of association members remained static. 74% of these payments went toward Research and Development (R&D), resulting in an increased investment of 33% in this specific area compared to 2015 (see figure). While the ABPI clearly expressed its willingness to collaborate with European countries in regard to R&D and pharmaceuticals in general, Life Sciences companies have shown a keen interest in investing in the UK. Other types of spends on HCPs and HCOs remained static compared to last year.
Consent has also increased, with disclosure at an individual level up to 65% compared to 55% the previous year. This is most likely a direct result of the ABPI’s efforts to promote full transparency by encouraging companies to gain consent for individual disclosures. Last year, the ABPI had called on companies to refuse payments to HCPs unless they agree to individual disclosure.
The Future of Disclosed Transparency Data
Transparency in the UK is here to stay and ABPI clearly stated its commitment to achieve a 100% consent rate. Now that companies have a more organized reporting process, they can start leveraging the transparency database on the ABPI website to detect potential breach of codes and confirm whether payments are consistent and appropriate across their organizations and beyond.
Since 2001, Polaris has helped Life Sciences companies around the world create, implement, manage and automate their transparency reporting. These efforts not only reduce costs and risks, but increase efficiencies across the organizations. Learn more about Polaris’ transparency reporting solutions here or contact us to find out how our experts can help your company.
https://pharmaphorum.com/news/abpi-hails-step-change-doctors-disclosing-pharma-payments/ABPI transparency database